STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma

ABSTRACT:

SUBMITTER: Najem H 

PROVIDER: S-EPMC11178548 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature